Blog

Certified Colorectal Surgeons Transform the Game: Reduced Mortality and Leaks in Laparoscopic Resections

Certified colorectal surgeons shine in laparoscopic low anterior resections! A study with 41,741 patients in Japan found colorectal-specific certified surgeons significantly lowered 30-day mortality (0.2%) and anastomotic leak rates (9.3%) compared to noncertified peers, especially those with biliary certification. The bottom line? When it comes to these surgeries, having a colorectal-certified surgeon on the team substantially reduces risks, ensuring smoother outcomes.

Journal Article by Yamaguchi S, Endo H (…) Sakai Y et 8 al. in Dis Colon Rectum

Copyright © The ASCRS 2023.

read the whole article in Dis Colon Rectum

open it in PubMed

Post-Surgery Employment: Japanese Colorectal Cancer Patients Achieve 79% Return Rate in 12 Months

Japanese colorectal cancer patients (stages I-III) witnessed promising employment outcomes within 12 months post-surgery, with a 79% return-to-work rate. The study identified risks for delayed return, including advanced tumor stage, stoma presence, severe complications, shorter work tenure, and lower return-to-work inclination. Factors contributing to unemployment at 12 months included stoma, reluctance to return, nonregular employment, lower income, national health insurance, and lack of private medical coverage. Results encourage healthcare providers to support patients in considering post-surgery work reintegration.

Journal Article by Fujita Y, Hida K (…) Obama K et 7 al. in Dis Colon Rectum

Copyright © The ASCRS 2023.

read the whole article in Dis Colon Rectum

open it in PubMed

Hernia Center Labels: No Clear Edge in Ventral Hernia Repair Outcomes

In the quest for superior hernia care, researchers explored designated hernia centers (DHCs). Analyzing over 14,000 ventral hernia repairs (VHRs) from 261 sites, they found no clear advantage to DHCs. Surprisingly, non-designated hernia centers (NDHCs) displayed fewer 30-day complications and lower one-year hernia recurrence rates. The message? Current hernia center labels might not guarantee better outcomes, urging a need for standardized criteria to truly enhance hernia care value in the United States.

Journal Article by Haskins IN, Huang LC (…) Perez AJ et 2 al. in Am J Surg

Copyright © 2023 Elsevier Inc. All rights reserved.

read the whole article in Am J Surg

open it in PubMed

Irreversible Nerve Damage: The Pre-op Pain Predictor for Chronic Post-op Pain in Inguinal Hernia Patients

Inguinal hernia patients with pre-op pain face potential irreversible nerve damage, signaling a road to chronic post-op pain (CPIP). Studying 40 patients who underwent hernia repair, researchers found intraneural fibrosis within the ilioinguinal nerve in all pre-op pain cases. The fibrosis degree correlated positively with pain duration. This unveils a crucial link between pre-op pain and lasting nerve injury, shedding light on the mysterious path to CPIP.

Journal Article by Narita M, Moriyoshi K (…) Hata H et 9 al. in Langenbecks Arch Surg

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

read the whole article in Langenbecks Arch Surg

open it in PubMed

Subtotal vs. Total Adrenalectomy in Bilateral Pheochromocytoma – Less Insufficiency, More Recurrence?

In the world of adrenal gland dilemmas, researchers delve into the showdown between total adrenalectomy and its hip sibling, subtotal adrenalectomy, for bilateral pheochromocytoma. Analyzing 10 studies with 1202 patients, they uncover that subtotal adrenalectomy, while saving from adrenal insufficiency, packs a punch with a higher recurrence rate (14.1% vs. 2.6%) and lower post-surgery steroid dependence (93.3% vs. 11.6%). Future battles call for randomized studies to confirm these adrenal wrestling outcomes.

Journal Article by Schiavone D, Ballo M (…) Iacobone M et 4 al. in BJS Open

© The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.

read the whole article in BJS Open

open it in PubMed

Navigating Neoadjuvant Therapies for Esophageal Cancer

In the exploration of treatments for advanced esophageal squamous cell carcinoma (ESCC), researchers compared outcomes of neoadjuvant chemotherapy (NCT), neoadjuvant chemoradiotherapy (NCRT), and neoadjuvant immunochemotherapy (NICT). NCRT and NICT groups exhibited superior pathological responses, with higher pathologic complete response rates (29.9% and 23.6%, respectively) compared to NCT (8.1%). NCRT significantly reduced lymph node metastasis in specific stations, highlighting its efficacy in select cases. Tailoring neoadjuvant strategies based on tumor characteristics emerges as crucial for optimizing therapeutic responses in ESCC.

Journal Article by Tian Y, Shi Z (…) Chen Y et 7 al. in Ann Surg Oncol

© 2023. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Intraperitoneal Paclitaxel Shows Promise: Effective and Tolerable Combo for Gastric Cancer with Peritoneal Metastasis

In a phase II study, researchers explored the efficacy of intraperitoneal paclitaxel combined with S-1 and cisplatin for gastric cancer with peritoneal metastasis. Among 53 patients, the treatment achieved a 73.6% 1-year overall survival rate, meeting the primary endpoint. The median survival time was 19.4 months, and the 1-year progression-free survival rate reached 49.6%. While well-tolerated, with manageable toxicities, the study highlights the potential of this combination therapy for patients facing gastric cancer with peritoneal metastasis.

Journal Article by Kobayashi D, Kodera Y (…) Kitayama J et 21 al. in Ann Surg Oncol

© 2023. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Insights from Percutaneous Transesophageal Gastro-Tubing in Japan

In a comprehensive study of 3,684 patients undergoing percutaneous transesophageal gastro-tubing (PTEG) in Japan, researchers found a mere 1.3% complication rate. PTEG served diverse purposes, with 1,455 cases for decompression and 2,193 for feeding. Notably, complications led to minimal invasive treatments, predominantly red blood cell transfusions and tube replacements. This real-world analysis not only sheds light on the safety of PTEG but also provides valuable practical insights, emphasizing its viability as an alternative intervention.

Journal Article by Nakama R, Inoue N (…) Fushimi K et 3 al. in BMC Surg

Copyright © 2023 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Impact and Strategies for Unplanned Conversions in Robotic Pancreaticoduodenectomy

In the robotic frontier of pancreaticoduodenectomy, a study of 400 patients revealed a 10.5% unplanned conversion rate. Men, especially, faced this detour, often due to vascular surprises or bleeding challenges. While conversions meant shorter surgeries, they spiked blood loss and complications, with higher mortality rates. Thankfully, conversion rates decreased over time, suggesting growing surgeon proficiency. The study recommends a stepwise approach for safer conversions, underscoring the need for strategic planning in this high-stakes robotic terrain.

Journal Article by Slavin M, Ross SB (…) Rosemurgy AS et 5 al. in Surg Endosc

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Beyond CT Scans: Nomogram Outshines in Predicting Lymph Node Metastasis in Colorectal Cancer

In a game-changing move for superficial colorectal cancer, researchers crafted a user-friendly nomogram for personalized lymph node metastasis (LNM) prediction after endoscopic surgery. Analyzing 608 cases, the nomogram trumped traditional CT scans, showcasing superior predictive power, as validated by ROC, DCA, and clinical impact curves. By spotlighting age, tumor features, and lipid levels, this tool shines in risk stratification, offering a noninvasive edge over conventional imaging methods.

Journal Article by Tang CT, Li J (…) Zeng CY et 2 al. in Surg Endosc

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed